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It has been unclear whether alteration in DNA methylation at cytokine genes during T helper (Th) cell differ-
entiation is a cause or consequence of gene expression. In this issue of Immunity, Ichiyama et al. (2015) show
that oxidation of 5-methylcytosine by the methylcytosine dioxygenase Tet2 regulates cytokine production in
Th cells.Cell-fate determination, including T helper
(Th) cell differentiation from naive CD4+
T cells, is often accompanied by the in-
ductionof lineage-specifying transcription
factors andepigenetic changesat the line-
age-specific gene loci (Kanno et al., 2012;
Zhu et al., 2010). T-bet, GATA-3, RORgt,
and Foxp3 are the key transcription fac-
tors in determining the fate of Th1, Th2,
Th17, and inducible regulatory T (iTreg)
cells, respectively. Besides a direct role
in transcriptional activation and/or repres-
sion, these key transcription factors might
also induce specificepigenetic changesat
cytokine gene loci, which include modifi-
cations to the DNA and associated his-
tones (Wilson et al., 2009). Genome-wide
mapping of the histone modifications in
CD4+ T lineages indicates that permissive
(H3K4me3) and suppressive (H3K27me3)
modifications at the signature cytokine
loci are associated with the activation or
silencing of these genes, respectively, in
specific lineages (Wei et al., 2009). In addi-
tion, changes in DNA methylation at cyto-
kine gene loci are observed when cells
gain the capacity to produce these cyto-
kines during Th cell differentiation (Ansel
et al., 2006). However, to date there is little
direct evidence to suggest that DNA de-
methylation is necessary for induction of
cytokine gene expression under physio-
logic conditions.
DNA methylation predominately occurs
at the 5-position of cytosine (5-methylcy-
tosine, 5mC) within CpG dinucleotides.
5mC pattern is inheritable during DNA
duplication and actively maintained by
DNA methyltransferases (Dnmts) (Koh
and Rao, 2013). Hypermethylation in
promoter and/or enhancer regions is
associated with heterochromatin and/orsilenced genes. Oxidation of 5mC by
ten-eleven translocation (Tet) family pro-
teins results in production of 5-hydroxy-
methylcytosine (5hmC), 5-formylcyto-
sine (5fC), and then 5-carboxylcytosine
(5caC). The methyl group is finally
removed by thymine DNA glycosylase
(TDG) through excision repair. 5hmC, the
first intermediate product during cytosine
demethylation, is relatively abundant in
the genome and much more stable than
5fC or 5caC, indicating that 5hmC might
serve as an important epigenetic mark.
The function of 5hmC, particularly in
T cells, is poorly understood because the
conventional bisulfite method to deter-
mine DNAmethylation status used in early
studies does not distinguish 5mC from
5hmC.
In this issue of Immunity, Ichiyama et al.
use DNA immunoprecipitation (DIP) with
specific antibodies to 5mC and 5hmC
followed by high-throughput sequencing
(DIP-Seq) to map these two modifications
genome-wide in distinct T helper cells that
were cultured in vitro (Ichiyama et al.,
2015). Dynamic changes of these two
modifications are noted in many lineage-
specific gene loci. The global distribution
patterns of either modification are similar
among various Th subsets, with a slight
enrichment of both modifications at
gene bodies. Interestingly, 5hmC is more
abundant in naive CD4+ T cells than
in differentiated T helper cells, which is
consistent with another genome-wide
profiling of 5hmC distribution in T cells
using a different method (Tsagaratou
et al., 2014). Binary marks of both 5mC
and 5hmC are present at 20% of the
5hmC-occupied regions indicating a po-
tential active DNA demethylation processImmunitywithin these regions during T cell differen-
tiation. Binary marks might exist at a
higher frequency if the 5mC DIP-seq
were to work more efficiently; many
known 5mCmarks in T cells from the liter-
ature including those located in an intron
of Foxp3 gene are not identified by 5mC
DIP-Seq and there is inconsistency be-
tween 5mC DIP-Seq and 5mC DIP-PCR
at certain regions suggesting that 5mC
DIP-Seq in this study might not be sensi-
tive enough to detect all the 5mC marks.
Nevertheless, the 5hmC marks are more
likely to co-localize with H3K4me3 modi-
fication than 5mC marks. Therefore,
5hmC marks are enriched in active and/
or poised genes. Indeed, many lineage-
specific 5hmC marks are identified within
the evolutionarily conserved non-coding
sequence (CNS) regions of the lineage-
specific genes, particularly effector cyto-
kine genes including Ifng and Il17a. By
contrast, fewer lineage-specific 5hmC
marks are present within the gene loci of
key transcription factors, such as Gata3
and Rorc. While 5mC marks are present
at the CNS (6 kb) of the Ifng gene in
naive CD4+ T cells and Th17 cells judged
by DIP-PCR results, 5hmC marks at this
region are only detected in Th1 cells
(Figure 1). 5hmC, but not 5mC, is prefer-
ential found in the regions with p300 bind-
ing, which defines active enhancers. In
addition, the binding sites for key tran-
scription factors such as T-bet, RORgt,
and STAT proteins substantially overlap
with 5hmC, but not 5mC in Th1
and Th17 cells, respectively. Therefore,
5hmC modification occurs at the regula-
tory DNA elements of lineage-specific
genes, many of which serve as active en-
hancers in distinct Th lineages.42, April 21, 2015 ª2015 Elsevier Inc. 593
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Figure 1. Tet2-Mediated 5hmC Modification Regulates the Expression of IFN-g, IL-17a, and
IL-10 in Th1 and Th17 cells
In naive CD4+ T cells, 5mC occupies the transcriptional regulatory regions of effector cytokine gene loci,
particularly in the enhancer regions that often overlap with conserved non-coding sequences (CNSs).
These cytokine genes are silenced in naive CD4+ T cells. During differentiation of naive CD4+ T cells
into distinct effector T helper cells, 5mC in these regulatory regions is oxidized to 5hmC by Tet proteins
in a lineage-specific manner. Recruitment of Tet2 to the CNS (6 kb) of Ifng locus in Th1 cells and to
the CNS2 of Il17 locus in Th17 cells depends on the key transcription factor, T-bet and RORgt, respec-
tively. Tet2 is important for 5hmC modification at the CNS (6 kb) of Ifng locus, optimal T-bet and p300
binding to this site, histone modification changes, as well as optimal Ifng transcription. The expression
of other cytokine genes including Il17a and Il10 is also regulated through a similar mechanism.
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PreviewsConversion from 5mC to 5hmC is cata-
lyzed by Tet family proteins, Tet1, Tet2,
and Tet3 (Koh and Rao, 2013). Ichiyama
et al. show that although all three Tet pro-
teins are expressed in naive CD4+ T cells,
their expression is downregulated during
T cell activation, leaving only Tet2 ex-
pressed in substantial amounts in various
Th lineages. Therefore, Tet2 seems to be
a reasonable candidate that is respon-
sible for 5hmC modification in distinct Th
lineages. Indeed, Tet2 binding is detected
at the CNS (6 kb) of Ifng and the CNS2 of
Il17 locus, where 5hmCmarks are present
in Th1 and Th17 cells, respectively. The
recruitment of Tet2 to these regions and
thus 5hmC modification depend on the
expression of key transcription factors
T-bet or RORgt, respectively. Conditional
deletion of the Tet2 gene in T cells with
Cd2-Cre affects the generation of cyto-
kine-producing cells. Tet2-deficient cells
differentiated into Th1 and Th17 lineages
have a substantial reduction of 5hmC
content at a genome scale. However,
only very few genes, such as Ifng, Il17a,
and Il10, are significantly affected. Tet2594 Immunity 42, April 21, 2015 ª2015 Elsevdeficiency not only results in a reduced
5hmC modification in the DNA regulatory
elements in these cytokine genes, it also
affects histone modification such as
H3K4me3, p300 binding, and key tran-
scription factor binding to these elements,
indicating that Tet2 and key transcription
factors such as T-bet might regulate
each other’s function in inducing cytokine
production.
Ichiyama et al. further show that Tet2
regulates autoimmune responses in vivo.
In an experimental autoimmune encepha-
lomyelitis (EAE) model, Tet2 expression in
CD4+ T cells restrains the disease severity
possibly through regulating IL-10 expres-
sion. However, when IL-10 signaling is
blocked, Tet2-deficient mice are more
resistant to EAE induction, presumably
due to impaired induction of IL-17-IFN-
g-dual-producing T cells. Therefore, Tet2
is important for regulating IFN-g, IL-17a,
and IL-10 production both in vitro and
in vivo.
This study by Ichiyama et al. sheds
light on the importance of Tet2-mediated
5mC oxidation at the regulatory elementsier Inc.of effector cytokine genes and the critical
function of such epigenetic change
in regulating cytokine expression. There
are several interesting issues need to be
resolved in the future. Is 5hmC, as an in-
termediate product, simply a readout for
active demethylation process or 5hmC
itself is important for gene regulation?
Many 5hmC-binding proteins have been
identified (Koh and Rao, 2013). So far, it
is unknown which protein(s) can bind to
5hmC in T cells. MeCP2, one of the
5mC binding proteins, is the major mole-
cule binds to 5hmC in neuronal cells; a
disease-causing mutant of MeCP2 lost
its ability to bind to 5hmC, but is still
able to interact with 5mC (Melle´n et al.,
2012). T cell-specific deletion of MeCP2
results in impaired cytokine production
by Th1 and Th17 cells, although the
mechanism for such defect is interpreted
differently in the report (Jiang et al.,
2014). Whether MeCP2 has a direct role
on effector cytokine production through
sensing a change from 5mC to 5hmC at
the cytokine loci requires further investi-
gation. In the future, it is also important
to determine the relationship among
5hmC marks, histone modifications and
transcription factor binding at the cyto-
kine gene loci. Furthermore, what is the
function of 5hmC marks at the hundreds
of lineage-specific genes whose expres-
sion is not altered but 5hmC marks are
reduced in the absence of Tet2? Are
these 5hmC marks important for terminal
differentiation of distinct lineages and/
or memory generation? What are the
5hmC patterns in T effector cells that
are generated in vivo?
Tet2 deficiency does not completely
eliminate 5hmC marks at the cytokine
gene loci in Th1 and Th17 cells. Also,
Tet2 deletion does not affect IL-17f
expression in Th17 cells, but the mecha-
nism for differential regulation of IL-17a
and IL-17f by Tet2 is unknown. In addi-
tion, Tet2 is dispensable for lineage-spe-
cific 5hmC marks at the key gene loci in
Th2 and iTreg cells. Consistent with this,
Tet2 does not bind to these 5hmC re-
gions in these cells and the expression
of the signature genes including IL-4 and
Foxp3 is not affected by Tet2 deficiency.
Our RNA-Seq data and previous reports
suggest that both Tet2 and Tet3 are ex-
pressed in T cells (Tsagaratou et al.,
2014). Therefore, Tet3 might play an
important role in 5hmC production in
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PreviewsTh2 and iTreg cells and also have some
contribution to 5hmC modification in Th1
and Th17 cells. The importance of 5mC
oxidation in promoting cytokine produc-
tionmight be underestimated by Ichiyama
et al. in their study. Experiments using
Tet2 and Tet3 doubly deficient cells and/
or mice might give the answers to these
unsolved important questions.
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NLRP12 is an innate immune receptor whose regulation of NF-kB signaling in myeloid cells is critical in pre-
ventingmultiple auto-inflammatory diseases. In this issue of Immunity, Lukens et al. (2015) show that a similar
NLRP12-mediated mechanism is functionally important in T cells.Nucleotide-binding domain and leucine-
rich repeat containing receptors (NLRs)
are a class of intracellular pattern recogni-
tion receptors (PRRs) of the innate im-
mune system whose functions appear to
be multifaceted. Whereas other classes
of PRRs, such as Toll-like receptors
(TLRs) and RIG-I-like receptors (RLRs),
primarily detect microbial ligands that
are indicative of a pathogenic insult,
NLRs seem to be involved in a wider vari-
ety of cellular functions, including micro-
bial recognition, but also the surveillance
of cellular integrity and the regulation of
intracellular signaling pathways. Most
NLRs with known functions can be
grossly categorized into two groups. The
first one is capable, upon triggering by a
multitude of exogenous and endogenous
stimuli, of assembling amulti-protein com-
plex called the inflammasome,which func-
tions to recruit and activate caspase-1,
leading to the cleavage and activation of
pro-interleukin-1b (IL-1b) and IL-18 into
their secreted forms (Henao-Mejia et al.,2014). The second group regulates the
canonical and non-canonical arms of
NF-kB signaling, a pivotal immune-modu-
latory intracellular pathway. One promi-
nent member of the latter class of NLRs
is NLRP12, originally described in overex-
pression assays as a negative regulator of
NF-kB-induced cytokine production,
when NLRP12 was still called PYPAF7 or
Monarch-1 (Wang et al., 2002). With the
generation of Nlrp12/ mice came the
realization that this NLR and its down-
stream control of NF-kB are critical to pre-
vent a multitude of immune-mediated or
-modulated diseases, including allergic
contact hypersensitivity (Arthur et al.,
2010), colitis, and colorectal cancer (Allen
et al., 2012; Zaki et al., 2011).
As diverse as the cellular functions of
NLRs are the cell types inwhich they oper-
ate. Originally discovered to be mainly
expressed and operational in myeloid
cells, the spectrum of tissues and cell
types in which NLRs are at play has
recently been expanded to other cells ofthe immune system and eventually even
to non-hematopoietic cells (Elinav et al.,
2011). In this issue of Immunity, Lukens
et al. (2015) have shown that this
expanded cellular diversity also holds
true in regard to NLRP12. Early reports
show that NLRP12 plays a prominent
role in mononuclear phagocytes, where it
regulates NF-kB-induced pro-inflamma-
tory cytokine production to inhibit auto-
inflammation (Allen et al., 2012; Arthur
et al., 2010; Zaki et al., 2011). Lukens
et al. (2015) have now demonstrated that
the expression and function of NLRP12
is not limited to the myeloid system. By
using a series of expression studies,
adoptive transfers, and bone marrow
chimera experiments, Lukens et al. (2015)
have found a T cell-intrinsic role for
NLRP12 in regulating NF-kB signaling
and pro-inflammatory cytokine produc-
tion. Phenotypically, the absence of
NLRP12 in T cells manifested in higher
expression of activation markers, en-
hanced cell proliferation, and elevated42, April 21, 2015 ª2015 Elsevier Inc. 595
